This compound is a protected nucleoside derivative used as an intermediate in the solid-phase synthesis of oligonucleotides. Its structure features a uridine base with an acetamide group and a 4,4′-dimethoxytrityl (DMT) protecting group on the 5′-hydroxyl, along with a 2′-O-methyl modification, making it suitable for RNA-based oligonucleotide assembly.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 199593-08-3
N-Acetyl-5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-(tert-butyl(dimethyl)silyl)cytidine
nucleoside protecting group intermediate
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
DMT-N4-Acetyl-2'-Deoxycytidine
Pharmaceutical intermediate for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N6-BENZOYL-2'-O-METHYL-ADENOSINE
nucleoside intermediate for oligonucleotide synthesis
1-Bromo-4-chloro-2-fluorobenzene
Pharmaceutical intermediate
4-[[[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyl]amino]benzoic acid
Pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
FINUHOJILDNELQ-PMFUCWTESA-N
CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)OC